Her Fantasy Box Fresh & Clean Boric Acid 600 mg, 30 Suppositories, EXP 04/2029

Six-dimension breakdown

Why this scored 44/100

Boric acid vaginal suppositories at 600mg are a legitimate second-line treatment for recurrent vulvovaginal candidiasis (particularly non-albicans Candida species like C. glabrata and C. krusei that are often azole-resistant) and for recurrent bacterial vaginosis unresponsive to antibiotics. The clinical evidence base is real: CDC's Sexually Transmitted Infections Treatment Guidelines list intravaginal boric acid 600mg/day for 14 days as an alternative treatment for recurrent VVC, and multiple published trials support the protocol. However, this product cannot be evaluated as a Vyvata supplement listing because it falls significantly outside the biohacking/longevity/wellness scope Vyvata covers, has serious safety implications requiring physician oversight (oral ingestion of boric acid is toxic — reported LD50 in adults is roughly 5-20g; vaginal use is safe only when not confused with oral use; pregnancy is a contraindication; the branding suggests recreational/OTC use rather than medical treatment), and the branding style ("Her Fantasy Box Fresh & Clean") frames a medical antifungal treatment as a cosmetic "freshness" product — which is exactly the class of positioning the FDA has warned against for vaginal boric acid products, as it misrepresents medical treatment as hygiene/cosmetic use and can normalize regular use of a compound that should be limited to specific clinical scenarios under physician direction. Rejected: out_of_scope_for_biohacking combined with misleading positioning as a hygiene product rather than a medical antifungal.

Evidence & sources

The Vyvata score's Evidence dimension measures the quality of published RCT support for a product's active ingredients at the label dose. Our source hierarchy: double-blind RCTs in MEDLINE-indexed journals > single-blind RCTs > open-label trials > observational studies > mechanism papers > N=1 case studies (anecdotes). Predatory journals and manufacturer-authored studies without independent replication are weighted down.

Product-specific evidence citations for this item are embedded in the analysis text on the "Analysis" tab. For the full framework and evidence hierarchy, see the methodology page.

How to read the Evidence dimension

• 80–100: Multiple double-blind RCTs in indexed journals directly testing this product OR the exact ingredients at the exact dose.
• 60–79: Single double-blind RCT + supporting ingredient literature at the studied dose.
• 40–59: Open-label trials + ingredient literature; no product-specific double-blind evidence.
• 20–39: Ingredient literature only; no product-specific trials or trials in predatory venues.
• 0–19: No credible evidence base or unverifiable claims.

FAQ data has not been generated for this product yet. See the site FAQ for general questions.

Customer reviews

All the data we have on this product

Every VSF-related metafield surfaced verbatim. Nothing hidden. If you spot data that looks wrong, let us know.

VSF score

44 / 100

Tier

Rejected

Category

Supplements

Subcategory

womens health

Last scored

August 30, 2026

Third-party certifications

None on record at time of scoring

Vendor

Take It or Leave It

Product type

suppository

Tags

Shopify Collective, Take It or Leave It

Every score is set from the published rubric, audit-logged, and rescored whenever new evidence emerges (published trials, updated labels, third-party testing releases). Every vendor is scored on the same criteria — no pay-to-play. See our editorial-independence disclosure for the full policy, including brands with an editorial relationship to this site.